ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.430,05
1,42%
S&P 500
5.185,50
0,09%
Dow Jones
38.871,98
0,05%
Euro vs US Dollar
1,07501
-0,16%
Bitcoin
63.213,37
0,08%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. CryoPort Inc (CYRX)

  7. CryoPort Inc (CYRX) News

CYRX

CryoPort (CYRX)

CryoPort Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CYRX
DatumZeitQuelleÜberschriftSymbolFirma
30/04/202414h30PR Newswire (US)Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:CYRXCryoPort Inc
12/03/202421h05PR Newswire (US)Cryoport Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CYRXCryoPort Inc
27/02/202414h30PR Newswire (US)Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024NASDAQ:CYRXCryoPort Inc
15/02/202422h42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYRXCryoPort Inc
14/02/202418h22Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CYRXCryoPort Inc
26/01/202422h23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CYRXCryoPort Inc
21/12/202322h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CYRXCryoPort Inc
20/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CYRXCryoPort Inc
19/12/202301h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYRXCryoPort Inc
15/12/202323h09Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CYRXCryoPort Inc
15/12/202323h05Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:CYRXCryoPort Inc
14/12/202300h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYRXCryoPort Inc
11/12/202323h09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYRXCryoPort Inc
27/11/202314h30PR Newswire (US)Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain ServicesNASDAQ:CYRXCryoPort Inc
16/11/202314h30PR Newswire (US)Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird ExpressNASDAQ:CYRXCryoPort Inc
15/11/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYRXCryoPort Inc
09/11/202320h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYRXCryoPort Inc
08/11/202322h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYRXCryoPort Inc
08/11/202322h05PR Newswire (US)Cryoport Reports Third Quarter 2023 Financial ResultsNASDAQ:CYRXCryoPort Inc
02/11/202313h30PR Newswire (US)Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH AcquisitionNASDAQ:CYRXCryoPort Inc
25/10/202314h30PR Newswire (US)Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023NASDAQ:CYRXCryoPort Inc
12/10/202314h30PR Newswire (US)Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVFNASDAQ:CYRXCryoPort Inc
10/10/202314h30PR Newswire (US)Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene TherapiesNASDAQ:CYRXCryoPort Inc
09/10/202322h05PR Newswire (US)Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene TherapiesNASDAQ:CYRXCryoPort Inc
14/09/202314h30PR Newswire (US)Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence AwardNASDAQ:CYRXCryoPort Inc
13/09/202323h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYRXCryoPort Inc
13/09/202300h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYRXCryoPort Inc
05/09/202323h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYRXCryoPort Inc
02/09/202300h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYRXCryoPort Inc
30/08/202323h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYRXCryoPort Inc
 Showing the most relevant articles for your search:NASDAQ:CYRX

Kürzlich von Ihnen besucht

NYSE
MCD
McDonalds
FX
EURGBP
Euro vs Sterling
NASDAQ
TSLA
Tesla
NYSE
KO
Coca Cola
DBI
DAX
DAX
CCOM
US500
US 500
USOTC
RHHBY
Roche (QX)
NASDAQ
NVDA
NVIDIA
USOTC
BASFY
BASF (QX)
TG
432
Arbor Metals
TG
D7G
Nel ASA
TG
RHM
Rheinmetall
AMEX
XLV
Health Care Select Sector
TG
NOV
Novo Nordisk
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten